{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:52:38Z","timestamp":1791571958870,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["(82371084)"],"award-info":[{"award-number":["(82371084)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-53536-x","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:04:49Z","timestamp":1780041889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SGLT2 inhibition with empagliflozin attenuates retinal oxidative stress and damage in diabetic mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Yutong","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiru","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"53536_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376, 124\u2013136. https:\/\/doi.org\/10.1016\/s0140-6736(09)62124-3 (2010).","journal-title":"Lancet"},{"key":"53536_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1167\/iovs.64.13.31","volume":"64","author":"Y Takamura","year":"2023","unstructured":"Takamura, Y. et al. Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema. Invest. Ophthalmol. Vis. Sci. 64, 31. https:\/\/doi.org\/10.1167\/iovs.64.13.31 (2023).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"53536_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-03663-y","author":"C Mishra","year":"2025","unstructured":"Mishra, C. & Kannan, N. B. Ultra-wide-field imaging of proliferative diabetic retinopathy with macular tractional retinal detachment and florid neovascularization. Eye (Lond). https:\/\/doi.org\/10.1038\/s41433-025-03663-y (2025).","journal-title":"Eye (Lond)"},{"key":"53536_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/s0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson, C. P. et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110, 1677\u20131682. https:\/\/doi.org\/10.1016\/s0161-6420(03)00475-5 (2003).","journal-title":"Ophthalmology"},{"key":"53536_CR5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2147\/ijn.S294807","volume":"16","author":"Y Liu","year":"2021","unstructured":"Liu, Y. & Wu, N. Progress of Nanotechnology in Diabetic Retinopathy Treatment. Int. J. Nanomed. 16, 1391\u20131403. https:\/\/doi.org\/10.2147\/ijn.S294807 (2021).","journal-title":"Int. J. Nanomed."},{"key":"53536_CR6","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.cmet.2024.04.013","volume":"36","author":"TF Dorweiler","year":"2024","unstructured":"Dorweiler, T. F. et al. Diabetic retinopathy is a ceramidopathy reversible by anti-ceramide immunotherapy. Cell. Metab. 36, 1521\u20131533. https:\/\/doi.org\/10.1016\/j.cmet.2024.04.013 (2024). e1525.","journal-title":"Cell. Metab."},{"key":"53536_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ajo.2024.10.019.(","volume":"270","author":"R Anguita","year":"2025","unstructured":"Anguita, R. et al. Early Versus Delayed Vitrectomy for Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy. Am. J. Ophthalmol. 270, 237\u2013244. https:\/\/doi.org\/10.1016\/j.ajo.2024.10.019.( (2025).","journal-title":"Am. J. Ophthalmol."},{"key":"53536_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00417-024-06660-1","volume":"263","author":"M Yuan","year":"2025","unstructured":"Yuan, M. et al. Clinical and imaging characteristics associated with foveal neovascularization in proliferative diabetic retinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 263, 679\u2013687. https:\/\/doi.org\/10.1007\/s00417-024-06660-1 (2025).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"53536_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/opth.S236637","volume":"14","author":"SE Mansour","year":"2020","unstructured":"Mansour, S. E., Browning, D. J., Wong, K., Flynn, H. W. Jr. & Bhavsar, A. R. The Evolving Treatment of Diabetic Retinopathy. Clin. Ophthalmol. 14, 653\u2013678. https:\/\/doi.org\/10.2147\/opth.S236637 (2020).","journal-title":"Clin. Ophthalmol."},{"key":"53536_CR10","doi-asserted-by":"publisher","unstructured":"Tomita, Y., Lee, D., Tsubota, K., Negishi, K. & Kurihara, T. Updates on the Current Treatments for Diabetic Retinopathy and Possibility of Future Oral Therapy. J. Clin. Med. 10 https:\/\/doi.org\/10.3390\/jcm10204666 (2021).","DOI":"10.3390\/jcm10204666"},{"key":"53536_CR11","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","volume":"51","author":"AW Stitt","year":"2016","unstructured":"Stitt, A. W. et al. The progress in understanding and treatment of diabetic retinopathy. Prog Retin Eye Res. 51, 156\u2013186. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.08.001 (2016).","journal-title":"Prog Retin Eye Res."},{"key":"53536_CR12","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.2147\/dddt.S269514","volume":"14","author":"N Li","year":"2020","unstructured":"Li, N. & Zhou, H. SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy. Drug Des. Devel Ther. 14, 4775\u20134788. https:\/\/doi.org\/10.2147\/dddt.S269514 (2020).","journal-title":"Drug Des. Devel Ther."},{"key":"53536_CR13","doi-asserted-by":"publisher","unstructured":"Schaub, J. A. et al. SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes. J. Clin. Invest. 133 https:\/\/doi.org\/10.1172\/jci164486 (2023).","DOI":"10.1172\/jci164486"},{"key":"53536_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","volume":"18","author":"C Li","year":"2019","unstructured":"Li, C. et al. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovasc. Diabetol. 18, 15. https:\/\/doi.org\/10.1186\/s12933-019-0816-2 (2019).","journal-title":"Cardiovasc. Diabetol."},{"key":"53536_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11892-021-01442-z","volume":"22","author":"CJ Bailey","year":"2022","unstructured":"Bailey, C. J., Day, C. & Bellary, S. Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease. Curr. Diab Rep. 22, 39\u201352. https:\/\/doi.org\/10.1007\/s11892-021-01442-z (2022).","journal-title":"Curr. Diab Rep."},{"key":"53536_CR16","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1167\/iovs.15-18658","volume":"57","author":"L Fan","year":"2016","unstructured":"Fan, L. & Yan, H. FTY720 Attenuates Retinal Inflammation and Protects Blood-Retinal Barrier in Diabetic Rats. Invest. Ophthalmol. Vis. Sci. 57, 1254\u20131263. https:\/\/doi.org\/10.1167\/iovs.15-18658 (2016).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"53536_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3238\/arztebl.2010.0075.(","volume":"107","author":"AN Kollias","year":"2010","unstructured":"Kollias, A. N. & Ulbig, M. W. Diabetic retinopathy: Early diagnosis and effective treatment. Dtsch. Arztebl Int. 107, 75\u201383. https:\/\/doi.org\/10.3238\/arztebl.2010.0075.( (2010). quiz 84.","journal-title":"Dtsch. Arztebl Int."},{"key":"53536_CR18","doi-asserted-by":"publisher","unstructured":"Rorex, C. et al. Astrogliosis in the GFAP-Cre(ERT2):Rosa26(iDTR) Mouse Model Does Not Exacerbate Retinal Microglia Activation or M\u00fcller Cell Gliosis under Hypoxic Conditions. Biomolecules 14 https:\/\/doi.org\/10.3390\/biom14050567 (2024).","DOI":"10.3390\/biom14050567"},{"key":"53536_CR19","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.redox.2021.101947","volume":"41","author":"MW Park","year":"2021","unstructured":"Park, M. W. et al. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer\u2019s diseases. Redox Biol. 41, 101947. https:\/\/doi.org\/10.1016\/j.redox.2021.101947 (2021).","journal-title":"Redox Biol."},{"key":"53536_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s10020-023-00651-4","volume":"29","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response. Mol. Med. 29, 57. https:\/\/doi.org\/10.1186\/s10020-023-00651-4 (2023).","journal-title":"Mol. Med."},{"key":"53536_CR21","doi-asserted-by":"publisher","unstructured":"Malaviya, P. & Kowluru, R. A. Homocysteine and mitochondrial quality control in diabetic retinopathy. Eye Vis. (Lond). 11 https:\/\/doi.org\/10.1186\/s40662-023-00362-1 (2024). 5.","DOI":"10.1186\/s40662-023-00362-1"},{"key":"53536_CR22","doi-asserted-by":"publisher","first-page":"838263","DOI":"10.3389\/fphar.2022.838263.(","volume":"13","author":"X Li","year":"2022","unstructured":"Li, X. et al. Dihydroartemisinin Inhibits Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular AMD. Front. Pharmacol. 13, 838263. https:\/\/doi.org\/10.3389\/fphar.2022.838263.( (2022).","journal-title":"Front. Pharmacol."},{"key":"53536_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-025-02043-7","volume":"13","author":"R Yang","year":"2025","unstructured":"Yang, R. et al. Lipid metabolism disorder promoting retinal structural and functional damage in ApoE(-\/-) mice with age superposition. Acta Neuropathol. Commun. 13, 125. https:\/\/doi.org\/10.1186\/s40478-025-02043-7 (2025).","journal-title":"Acta Neuropathol. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53536-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53536-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:10:21Z","timestamp":1786317021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53536-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53536"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53536-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":". A DR mouse model was established by STZ injection combined with a high-fat diet. The diabetic retina exhibits pathological changes characteristic of diabetic retinopathy. EMPA treatment was administered by injection and is proposed to alleviate diabetic retinal injury by reducing lipid peroxidation and oxidative stress, inhibiting M\u00fcller gliosis, improving mitochondrial homeostasis, and preserving tight junction integrity, including ZO-1 and occludin expression.","order":2,"name":"Ethics","label":"Schematic diagram showing the experimental design and the proposed protective effects of EMPA on DR","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24597"}}